Gapping down
In reaction to disappointing earnings/guidance:
- SWIR -23.9%, FOSL -16.6%, NGD -13.7%, RYAM -12.8%, LPI -11.6%, BKD -10.7%, CTL -10.2%, IIIV -8.9%, NTAP -7.9%, MMLP -7.6%, FNF -6.9%, SIX -6.4%, BCOV -5.8%, QTWO -5.6%, SKT -5.5%, POOL -4.7%, TPX -4.5%, AEG -4.4%, ASGN -4.3%, IFF -4.2%, EQM -4.2%, CRY -4.1%, PXD -3.8%, AIG -3.8%, TRU -3.8%, SPWR -3.7%, BWA -3.4%, AVP -3.4%, WLH -3.2%, KO -2.7%, WSO -2.6%, TSE -2.4%, CS -2.3%, NUS -2.2%, WMB -2% (also Targa Resources and Williams Cos (WMB) announce new NGL agreements and option for Mont Belvieu fractionation joint venture), MGM -1.9%, PS -1.9%, PPL -1.3%, ARI -1.1%
Other news:
- MTFB -77.2% (receives Complete Response Letter from the FDA regarding the New Drug Application for iclaprim for the treatment of acute bacterial skin and skin structure infections)
- INO -16.9% (prices offering of $65.0 mln aggregate principal amount of 6.50% convertible senior notes due 2024)
- XERS -6.1% (prices offering of 5.88 mln shares of common stock at $10.00 per share)
- HUBS -4.1% (commences underwritten public offering of 1.7 mln shares of common stock)
Analyst comments:
- ALGN -1.7% (downgraded to Neutral from Buy at UBS)
- CMA -1.1% (downgraded to Market Perform from Outperform at BMO Capital Markets)
Gapping up
In reaction to disappointing earnings/guidance:
- IVC +20.9%, CYBR +14.6%, SNBR +14.3%, MFGP +13.6%, YETI +10.7%, BLMN +6.6%, AZN +6.1%, PDS +6.1%, VNDA +5.1%, CSCO +4.5%, STNG +4.3%, GLOG +3.7%, AR +3.6%, CTRE +3.5%, TRTN +3.5%, GOOS +3.2%, DIOD +2.9%, ZBRA +2.7%, YELP +2.1%, ETRN +2.1%, BAM +2.1%, MRO +1.7%, IRM +1.7%, TU +1.7%, ZTS +1.5%, CCEP +1.4%, WM +1.4%, SBGL +1.2%, EQIX +1.1%, .
Other news:
- SOLO +28.4% (continued momentum after hosted virtual roadshow webinar yesterday)
- DBVT +12.3% (announces that its planned resubmission of the Biologics License Application to the FDA for Viaskin Peanut in the treatment of peanut-allergic children 4 to 11 years of age is anticipated in Q3)
- MDGS +9.6% (considering expanding portfolio of activities to include ventures in the field of CBD and medical cannabis in territories outside the US)
- CVRS +7.9% (seeks pre-market clearance from the FDA to use the CorPath GRX System in neurovascular intervention)
- GNC +6.5% (announces that Harbin Pharmaceutical has completed the final $150 mln investment of its previously announced $300 mln strategic investment)
- MDR +2.6% (modestly rebounding from yesterday's 27% decline), .
Analyst comments:
- CDXC +5.8% (initiated with a Buy at B. Riley FBR; tgt $7)
- ELVT +4.3% (upgraded to Buy with $6 tgt at BTIG)
- SYF +1.4% (upgraded to Buy from Neutral at Goldman)
- XOM +1.3% (upgraded to Outperform from Underperform at Macquarie)
- TEVA +1.1% (upgraded to Outperform from Mkt Perform at Raymond James)
![]()
Early premarket gappersGapping up:
- SOLO +33.5%, IVC +20.9%, SNBR +14.3%, DBVT +12.1%, YETI +6.6%, YETI +6.6%, GNC +6.5%, NGD +6.5%, AZN +6%, VNDA +4.8%, ELVT +4.3%, CSCO +4%, EQM +4%, STNG +3.7%, AR +3.6%, YELP +3.5%, CTRE +3.5%, TRTN +3.5%, DIOD +2.9%, ETRN +2.1%, IRM +1.7%, PDS +1.4%, SIX +1.3%, MRO +1.2%, EQIX +1.1%, MDR +1%, AVP +1%, BAND +0.9%, GNRC +0.9%
Gapping down:
- SWIR -21.4%, FOSL -18.8%, INO -15.4%, BKD -13.8%, RYAM -12.8%, CTL -12.2%, IIIV -8.9%, NTAP -8.1%, FNF -6.9%, MMLP -6.7%, BCOV -5.8%, LPI -4.7%, PXD -4.6%, ASGN -4.3%, IFF -4.2%, CRY -4.1%, AEG -3.9%, SPWR -2.4%, TSE -2.4%, CS -2.4%, NUS -2.2%, BWA -2.2%, AIG -2.1%, WMB -2.1%, MYOK -1.9%, PS -1.9%, HUBS -1.8%, MGM -1.8%
After Hours Summary: SNBR +12%, YELP +6%, CSCO +4% are higher, while SWIR -22%, FOSL -16%, BKD -14%, CTL -11%, NTAP -7%, AIG -3% are lower following earnings/guidanceAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: IVC +21.2%, SNBR +11.8%, YELP +5.8%, CSCO +3.8% (also raises quarterly dividend 6%; approved a $15 billion increase to the authorization of the stock repurchase program), VNDA +3.7%, DIOD +3.5%, AR +3.1%
Companies trading higher in after hours in reaction to news: SOLO +23.3% (continued momentum after hosting virtual roadshow webinar today), DBVT +17.9% (announces that its planned resubmission of the Biologics License Application to the FDA for Viaskin Peanut in the treatment of peanut-allergic children 4 to 11 years of age is anticipated in Q3), AVP +8.6% and YETI +0.8% (ahead of earnings tomorrow), ELVT +4.3% (upgraded to Buy with $6 tgt at BTIG), GNC +3.8% (announces that Harbin Pharmaceutical has completed the final $150 mln investment of its previously announced $300 mln strategic investment), MDR +1.6% (modestly rebounding from today's 27% decline), HLIT +1.5% (ticking higher; initiated with Buy at Needham)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: SWIR -21.9%, FOSL -16%, BKD -13.8%, RYAM -11% (light volume), CTL -10.7%, QTWO -7.5% (light volume), NTAP -7%, FNF -6.9%, BCOV -5.8% (light volume), MMLP -5.8%, IFF -4.5%, ASGN -4.3%, PXD -4.1%, AIG -3.2%, MGM -2.8%, TRUP -2.8% (light volume), NUS -2.2% (light volume), SPWR -2%, WMB -2% (also Targa Resources and Williams Cos announce new NGL agreements and option for Mont Belvieu fractionation joint venture), PS -1.9%, LPI -1.8%, SVMK -1.5%, H -1.2%
Companies trading lower in after hours in reaction to news: INO -15.2% (proposes offering of $65 mln convertible senior notes due 2024), HUBS -2.3% (commences offering of 1.7 mln shares of common stock), MYOK -1.9% (indicated lower on block trade pricing), CIM -0.5% (downgraded to Hold from Buy at Deutsche Bank
![]()